首页 | 本学科首页   官方微博 | 高级检索  
检索        

糖皮质激素对哮喘大鼠Clara细胞分泌蛋白表达的影响
引用本文:罗凤鸣,王曾礼,刘小菁,刘春涛,章小红,王文志.糖皮质激素对哮喘大鼠Clara细胞分泌蛋白表达的影响[J].中华结核和呼吸杂志,2002,25(9):538-541.
作者姓名:罗凤鸣  王曾礼  刘小菁  刘春涛  章小红  王文志
作者单位:1. 610041,成都,四川大学华西医院呼吸科
2. 610041,成都,四川大学华西医院内科实验室
基金项目:国家自然科学基金资助项目 (3 9770 3 40 )
摘    要:目的 观察吸入糖皮质激素对大鼠支气管哮喘 (简称哮喘 )模型肺组织Clara细胞分泌蛋白 (CCSP)mRNA表达的影响。方法 用卵白蛋白 (OVA)致敏、雾化建立大鼠哮喘模型 ,以逆转录 聚合酶链反应 (RT PCR)、斑点免疫印迹法 ,分别检测大鼠激发哮喘 3天后肺组织CCSPmRNA表达水平、支气管肺泡灌洗液 (BALF)CCSP蛋白浓度及雾化吸入布地奈德的影响。结果 哮喘组大鼠肺组织CCSPmRNA表达量为 0 .5 6± 0 .0 5 ,与正常对照组 (0 .6 5± 0 .0 4 )比较差异有显著性 (P <0 .0 1) ;激素治疗组CCSPmRNA表达量为 0 .6 3± 0 .0 4 ,与哮喘组 (0 .5 6± 0 .0 5 )比较差异也有显著性 (P <0 .0 5 )。哮喘组大鼠BALF中CCSP蛋白含量为 4 9± 5 ,与正常对照组 (6 0± 5 )比较 ,差异有显著性 (P <0 .0 1) ;激素治疗组CCSP蛋白含量 (5 7± 5 )与哮喘组比较 (P <0 .0 5 ) ,BALF中嗜酸细胞比例降低 ,气道炎症反应减轻。结论 CCSPmRNA表达减少导致CCSP水平下降 ,从而促进气道炎症而参与哮喘发病。雾化吸入糖皮质激素可增加CCSPmRNA表达 ,抑制哮喘气道炎症。

关 键 词:糖皮质激素  哮喘  Clara细胞分泌蛋白  布地奈德
修稿时间:2002年4月26日

Effect of budesonide on Clara cell secretory protein and its mRNA expression in a rat model of asthma
LUO Fengming ,WANG Zengli,LIU Xiaojing,LIU Chuntao,ZHANG Xiaohong,WANG Wenzhi.Effect of budesonide on Clara cell secretory protein and its mRNA expression in a rat model of asthma[J].Chinese Journal of Tuberculosis and Respiratory Diseases,2002,25(9):538-541.
Authors:LUO Fengming  WANG Zengli  LIU Xiaojing  LIU Chuntao  ZHANG Xiaohong  WANG Wenzhi
Institution:Department of Respiratory Disease, Huaxi Hospital of Sichuan University, Chengdu 610041, China.
Abstract:OBJECTIVE: To investigate the effect of inhaled glucocorticoids on the expression of Clara cell secretory protein (CCSP) and its mRNA in lung tissue of a rat model of asthma. METHODS: The rat asthmatic model was established by sensitizing and challenging SD rats with aerosolized ovalbumin (OVA). Rats were divided into a control, an asthmatic and a glucocorticoid groups. Budesonide aerosol was delivered by a jet nebulizer. The CCSP mRNA level in the lung tissue and the CCSP level in bronchoalveolar lavage fluid (BALF) were determined by RT-PCR and dot immuno-blotting, respectively. RESULTS: The level of CCSP mRNA in the lung tissue was 0.65 +/- 0.04 in the control, 0.56 +/- 0.05 in the asthmatic and 0.63 +/- 0.04 in the glucocorticoid groups, respectively (asthma versus control, P < 0.01; glucocorticoid versus asthma, P < 0.05). The CCSP level in BALF was 60 +/- 5 in the control, 49 +/- 5 in the asthmatic and 57 +/- 5 in the glucocorticoid groups, respectively (asthma versus control, P < 0.01; glucocorticoid versus asthma, P < 0.05). Budesonide reduced the percentage of eosinophils in BALF and inhibited airway inflammation. CONCLUSIONS: OVA challenge in the rat model decreased CCSP mRNA, resulting in a reduction in CCSP production, which may contribute to asthmatic airway inflammation. Inhaled glucocorticoids increased the expression of CCSP mRNA in lung tissue, which may be a mechanism for the suppression of airway inflammation by glucocorticoids.
Keywords:Asthma  Clara cell secretory protein  Glucocorticoids  budesonide
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号